Repeated doses of psilocybin show promise for treating obsessive-compulsive disorder
A new clinical trial suggests that multiple doses of psilocybin, the active compound in “magic mushrooms,” could provide substantial relief for individuals suffering from obsessive-compulsive disorder. The findings indicate that repeated weekly treatments are safe and tend to significantly reduce the severity of obsessive thoughts and compulsive behaviors. This research, published in the https://doi.org/10.1177/02698811261424214” target=”_blank”>Journal of Psychopharmacology, provides evidence for a new potential treatment avenue for those who have not found success with standard therapies. Obsessive-compulsive disorder is a debilitating psychiatric condition characterized by intrusive thoughts and repetitive behaviors. These symptoms consume a significant amount of time and can severely disrupt daily functioning. Current standard treatments typically include a combination of cognitive behavioral therapy and daily medications like serotonin reuptake inhibitors. However, these traditional approaches often fall short for many patients. People frequently experience delayed or incomplete symptom relief, and they sometimes struggle to adhere to the treatments due to unwanted side effects. Because of these challenges, scientists have sought alternative therapeutic approaches that might offer faster or more robust relief. Psilocybin has recently emerged …
